JAZZ vs OSK · P/E 1988, rev $2.28B vs P/E 15, rev $10.42B
Jazz Pharmaceuticals PLC (JAZZ) versus Oshkosh Corporation (OSK) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Oshkosh Corporation (OSK) is a farm & heavy construction machinery company listed on NYSE.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported OSK revenue for 2025-12-31 was $10.42B. Net income was $647.0M. Revenue was down 2.9% from 2024-12-31 to 2025-12-31. OSK currently screens at market cap $8.59B and trailing P/E 15.2.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. OSK currently screens at market cap $8.59B and trailing P/E 15.2.
Not investment advice. Open the JAZZ and OSK stock pages for the full models.
Not investment advice.